Arsenic trioxide for reprogramming the bone marrow microenvironment to eliminate acute myeloid leukemia blasts. [PDF]
Kegyes D +7 more
europepmc +1 more source
Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1 [PDF]
core +1 more source
Acute arsenic trioxide inhibits the cardiac transient outward K<sup>+</sup> current (I<sub>to</sub>) and human K<sub>v</sub>4.3/KChIP2c channels. [PDF]
Mancilla Simbro C +16 more
europepmc +1 more source
Arsenic trioxide-induced acute kidney injury: OPA1- and Drp1-mediated mitochondrial dynamics imbalance, PINK1/Parkin-dependent mitophagy, and Chuanhuang Fang III. [PDF]
Wang P +5 more
europepmc +1 more source
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy [PDF]
Ezhilarasi Chendamarai +15 more
openalex +1 more source
[Expression of Concern] S100A8‑targeting siRNA enhances arsenic trioxide‑induced myeloid leukemia cell death by down‑regulating autophagy. [PDF]
Yang L +8 more
europepmc +1 more source
Arsenic Trioxide, a Novel Mitochondriotoxic Anticancer Agent? [PDF]
Guido Kroemer, Hugues de Thé
openalex +1 more source
Arsenic trioxide regulates DYNAP through hsa-mir-573 and inhibits the proliferation of laryngeal cancer. [PDF]
Ren Y +8 more
europepmc +1 more source

